Exact Sciences Appoints Industry Analyst To New BD Role
This article was originally published in Clinica
Exact Sciences Corp., maker of the Cologuard, a colorectal cancer screening test, appointed Jeff Elliott VP, business development and strategy, effective June 20. In the new role, Elliott will oversee the identification and pursuit of strategic business opportunities to help drive Cologuard's success. Elliott previously served as a senior research analyst at Robert W. Baird & Co., monitoring diagnostics and life science tools companies. Previously, he worked in a supply chain role for Walgreen Co.and as a consultant at Cap Gemini Ernst & Young. Elliott will report directly to Kevin Conroy, chairman and CEO of Exact Sciences.